In contrast, chronic hyperinsulinemia contributes to a combination of hepatic insulin resistance in which the insulin-dependent activation of lipogenic gene expression remains intact, but gluconeogenic gene expression is inadequately repressed[5,30,33]. The gene discussed is INS; the disease is hyperinsulinism.